Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid

Journal of Hypertension

Volumn 19, Issue 5, 2001, Pages 983-992

  Imig, John D ^a   Zhao, Xueying ^a   Falck, John R ^b   Shouzou, Wei ^c   Capdevila, Jorge H ^c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytochrome P450 metabolites; Endothelium derived hyperpolarizing factor (EDHF); Epoxyeicosatrienoic acid; Hypertension; Kidney

Indexed keywords

ANGIOTENSIN; CYTOCHROME P450 2C11; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; SULFONAMIDE;

ANIMAL MODEL; ARTICLE; GAS CHROMATOGRAPHY; HYPERPOLARIZATION; HYPERTENSION; JUXTAGLOMERULAR APPARATUS; KIDNEY BLOOD FLOW; KIDNEY TUBULE ABSORPTION; MALE; MASS SPECTROMETRY; MICROSOME; MICROVASCULARIZATION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; WESTERN BLOTTING;

EID: 0035024260     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200105000-00020     Document Type: Article

References (30)

1. 1 Imig JD. Epoxyeicosatrienoic acids: biosynthesis, regulation and actions. In: Lianos EA (editor): Methods in molecular biology: eicosanoid protocols. Totowa, New Jersey: Humana Press Inc.; 1999. pp. 173-192.
2. 2 Makita K, Falck JR, Capdevila JH. Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old system. FASEB J 1996; 10:1456-1463.
3. 3 Imig JD, Navar LG, Roman RJ, Reddy KK, Falck JR. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 1996; 7:2364-2370.
4. 4 Imig JD, Inscho EW, Deichmann PC, Reddy KM, Falck JR. Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A. Hypertension 1999; 33:408-413.
5. 5 Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996; 78:415-423.
6. 6 Cowley AW, Roman RJ. The role of the kidney in hypertension. JAMA 1996; 275:1581-1589.
7. 7 Imig JD. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II-induced hypertension. Am J Hypertens 2000; 13:810-818.
8. 8 Mitchell KD, Navar LG. Angiotensin II administration as an experimental model of hypertension. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysiology, diagnosis, and management, 2nd edn. New York: Raven Press; 1995. pp. 1437-1450.
9. 2 and modulation by lipoxygenase and cytochrome P450 pathways. Am J Physiol: Renal Physiol 1997; 273:F274-F282.
10. 10 Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, et al. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997; 100:2816-2823.
11. 11 Omata K, Abraham NG, Schwartzman ML. Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am J Physiol: Renal Physiol 1992; 262:F591-F599.
12. 12 Romero MF, Madhun ZT, Hopfer U, Douglas JG. An epoxygenase metabolite of arachidonic acid 5,6-epoxyeicosatrienoic acid mediates angiotensin-induced natriuresis in proximal tubular epithelium. Adv Prostagl Thrombox Leukotr Res 1991; 21:205-208.
13. 13 Imig JD, Falck JR, Gebremedhin D, Harder DR, Roman RJ. Elevated renovascular tone in young spontaneously hypertensive rats: role of cytochrome P450. Hypertension 1993; 22:357-364.
14. 14 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
15. 15 Zou AP, Imig JD, Ortiz de Montellano PR, Sui Z, Roman RJ. Inhibition of renal vascular 20-HETE impairs autoregulation of renal blood flow. Am J Physiol: Renal Physiol 1994; 266:F275-F282.
16. 16 Capdevila J, Chacos N, Werringloer J, Prough RA, Estabrook RW. Liver microsomal cytochrome P450 and the oxidative metabolism of arachidonic acid. Proc Natl Acad Sci USA 1981; 78:5362-5366.
17. 17 Capdevila JH, Dishman E, Karara A, Falck JR. Cytochrome P450 arachidonic acid epoxygenase: stereochemical characterization of epoxyeicosatrienoic acids. Methods Enzymol 1991; 206:441-453.
18. 18 Abraham G, Simon G. Autopotentiation of pressor responses by subpressor angiotensin II in rats. Am J Hypertens 1994; 7:269-275.
19. 19 Bell-Quilley CP, Lin YSR, Hilchey SD, Drugge ED, McGiff JC. Renovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases. J Pharmacol Exp Therapeut 1993; 267:676-682.
20. 20 Feldman RD, Gros R. Impaired vasodilator function in hypertension: the role of alterations in receptor-G protein coupling. Trends Cardiovasc Med 1998; 8:297-305.
21. 21 Chatziantoniou C, Ruan X, Arendshorst WJ. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol: Renal Physiol 1993; 265:F573-F852.
22. 22 Karara A, Makita K, Jacobson HR, Falck JR, Guengerich FP, DuBois RN, Capdevila JH. Molecular cloning, expression and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenases. J Biol Chem 1993; 268:13565-13570.
23. 23 Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999; 401:493-497.
24. 24 Wang MH, Stec DE, Balazy M, Mastyugin V, Yang CS, Roman RJ, Schwartzman ML. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid w-hydroxylation and 11,12-epoxidation by CYP4A2. Arch Biochem Biophys 1996; 336:240-250.
25. 25 Messer-Letienne I, Bernard N, Benzoni D, Sassard J. Cytochrome P-450-dependent arachidonate metabolites and renal functions in the Lyon hypertensive rat. Clin Exp Pharmacol Physiol 1998; 26:559-563.
26. 26 Monneret G, Sassard J, Benzoni D. Renal effects of cP450 arachidonate metabolites in the Lyon hypertensive rat. Fundam Clin Pharmacol 1999; 13:226-231.
27. 27 Chin SY, Wang C, Majid DSA, Navar LG. Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat. Am J Physiol: Renal Physiol 1998; 274:F876-F882.
28. 28 Navar LG, Ichihara A, Chin SY, Imig JD. Nitric oxide-angiotensin II interactions in angiotensin II dependent hypertension. Acta Physiological Scand 2000; 168:139-147.
29. 29 Yu Z, Huse LM, Adler P, Graham L, Ma J, Zeldin DC, Kroetz DL. Increased CYP2 J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney. Mol Pharmacol 2000; 57:1011-1020.
30. 30 Jackson EK, Herzer WA. Defective modulation of angiotensin II-induced renal vasoconstriction in hypertensive rats. Hypertension 1994; 23: 329-336.